Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2011-03-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and relates to the preparation and application of a monoclonal antibody against mycobacterium tuberculosis early secretory antigen target protein (ESAT-6). Clone the hybridoma cell line of the antibody, induce ascites from the same strain of mice, prepare the anti-EAST-6 monoclonal antibody TBEF3, identify it as IgM, κ type, and then realize the antibody through affinity purification, electrophoresis, immunization and other technologies Applications. Background technique
[0002] Early diagnosis of tuberculosis is an important problem that has been plaguing the field of medical diagnosis. In the 20th century, due to the development and wide application of antibiotic research, humans successfully controlled tuberculosis. However, due to the continuous emergence and accumulation of drug resistance, Mycobacterium tuberculosis is still a real threat to human beings in the 21st century. More seriously,...